AngioDynamics, Inc. (ANGO)

10.35 -0.12 (-1.15%) USD  |  NASDAQ  |  Apr 15, 16:00
10.35 0.00 (0.00%) After-Hours: 20:00
More

AngioDynamics Research and Development Expense (Annual) : 26.22M for May 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for ANGO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Intuitive Surgical, Inc. 1.312B
Boston Scientific Corp. 2.052B
Masimo Corp. 126.40M
Globus Medical, Inc. 146.94M
InspireMD, Inc. 15.00M